Literature DB >> 183139

Immune destruction of virus-infected cells early in the infectious cycle.

S L Shore, T L Cromeans, T J Romano.   

Abstract

Mesh：

Substances：

Year:  1976        PMID： 183139     DOI： 10.1038/262695a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  23 in total

1.  Antibody-dependent cellular protection against herpes simplex virus dissemination as revealed by viral plauqe and infectivity assays.

Authors:  F Shimizu; K Hanaumi; Y Shimizu; K Kumagai
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

2.  Participation of three major glycoprotein antigens of herpes simplex virus type 1 early in the infectious cycle as determined by antibody-dependent cell-mediated cytotoxicity.

Authors:  B Norrild; S L Shore; T L Cromeans; A J Nahmias
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

3.  Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.

Authors:  Kening Wang; Georgia D Tomaras; Sinthujan Jegaskanda; M Anthony Moody; Hua-Xin Liao; Kyle N Goodman; Phillip W Berman; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayapan; Jaranit Kaewkungwal; Barton F Haynes; Jeffrey I Cohen
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

4.  Suppression of in vitro growth of virulent and avirulent herpes simplex viruses by cell-mediated immune mechanisms, antibody, and interferon.

Authors:  F Shimizu; J Satoh; M Tada; K Kumagai
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

Review 5.  Mechanisms of recovery from Herpesvirus infections -a review.

Authors:  B T Rouse; L A Babiuk
Journal:  Can J Comp Med       Date:  1978-10

6.  Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression.

Authors:  E Ojo-Amaize; P G Nishanian; D F Heitjan; A Rezai; I Esmail; E Korns; R Detels; J Fahey; J V Giorgi
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

7.  Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes.

Authors:  L H Perrin; R M Zinkernagel; M B Oldstone
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

8.  In vitro studies on the mechanism of herpesvirus plaque growth inhibition by sensitized lymphocytes.

Authors:  Y M Centifanto; Z S Zam; H E Kaufman
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  A possible role for polymorphonuclear leucocytes in the defence against recrudescent herpes simplex virus infection in man.

Authors:  A S Russell; C Miller
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.